Novacyt Group Archives - Page 36 of 36

13 Apr Novacyt raises €2.2M to accelerate NOVAPREP launch in China and announces strong first quarter sales growth

Posted at 15:46h in Novacyt Group

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces a private equity placement financing of €2.2m. This new financing will be used to accelerate the...

10 Mar Novacyt appoints new Group Commercial Director

Posted at 10:08h in Board, Novacyt Group

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has appointed Manuela Gazzard as Commercial Director. Download press release...

26 Jan Novacyt Revenues Full Year 2014

Posted at 15:48h in Novacyt Group

Novacyt (ISIN Code: FR0010397232 - Mnemonic code: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its unaudited revenues for 2014. Download press release...

22 Jan Initial coverage

Posted at 15:51h in Novacyt Group

Novacyt (ISIN Code: FR0010397232 - Mnemonic code: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that Oriel Securities, a stock market research firm, based in London, has initiated...

15 Dec Transition to continuous trading

Posted at 15:52h in Novacyt Group

Novacyt (ISIN Code: FR0010397232 - Mnemonic code: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that its stock will transition to continuous trading starting 15th of...

08 Dec Novacyt announces a €3.1M capital raise and prepares for new market launches

Posted at 15:54h in Novacyt Group

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces a private equity placement financing of €3.1m. Download press release...

30 Oct Novacyt announces 2014 Half Year Results and updates strong progress with integration of Lab21

Posted at 15:56h in Novacyt Group

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its half year results for the six months ended 30th June 2014 approved by the Board...

24 Jul Revenues for the six months to June 30, 2014

Posted at 15:58h in Novacyt Group

Novacyt (Mmemo: ALNOV - FR0010397232) announces its sales for the six months ended June 30, 2014. Download press release...

16 Jun Novacyt and Lab21 Announce stock for stock Completion

Posted at 16:02h in Novacyt Group

Novacyt (NYSE-ALTERNEXT: ALNOV), a leading diagnostics manufacturer that develops and markets innovative solutions in liquid-based cytology for the detection of cancer, including cervical cancer and other non-gynaecological cancers, and Lab21,...

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others